China Condemns US Bill Restricting Biotech Firms
China has criticized a new US bill that seeks to limit business with Chinese biotech firms like Wuxi AppTec and BGI. The Chinese foreign ministry labeled the action as discriminatory and urged the US to adhere to market principles and trade rules.
- Country:
- China
China has condemned the United States over a newly passed bill that aims to restrict business activities with Chinese biotech firms such as Wuxi AppTec and BGI. According to China’s foreign ministry, the legislation is a discriminatory measure against Chinese companies.
Ministry spokesperson Mao Ning emphasized during a press briefing that China urges the US to respect market principles and trade rules. Further, the US was advised to halt the advancement of the bill and to refrain from misusing various excuses to suppress Chinese companies.
The bill's passage is seen as part of ongoing tensions between the two nations regarding trade practices and market access.
ALSO READ
-
China Expands HealthWISE Training to Help Health Workers Tackle Risks at Job
-
MP CM Mohan Yadav inaugurates Women’s Asian Champions Trophy 2026 in Bhopal, cheers for team India
-
India rally past Malaysia 4-1 to begin title defence at Women’s Asian Champions Trophy 2026
-
President Murmu receives credentials from envoys of Greece, Spain, Nepal
-
South Korea's exports cross USD 1 trillion for first time on AI-driven semiconductor boom
Google News